Article
Irvine, CA-The FDA has issued ISTA Pharmaceuticals Inc. an approvable letter for Istalol (timolol), a once-daily liquid formulation for the treatment of glaucoma.
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.